This NIH grant, part of the Rapid Acceleration of Diagnostics-Radical (RADx-rad) initiative, aims to enhance chemosensory testing as a COVID-19 screening tool. The National Institutes of Health offers expedited funding for novel, non-traditional approaches to identify SARS-CoV-2 or other COVID-19 markers, applicable to future outbreaks. This grant seeks proposals for objective tests examining chemosensory loss’s onset and prognostic value, and encourages developing/deploying home-based and on-site chemosensory tests. Funded by the Paycheck Protection Program and Health Care Enhancement Act, this grant supports crucial public health diagnostics.
Opportunity ID: 328570
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-OD-20-022 |
Funding Opportunity Title: | Emergency Awards: Chemosensory Testing as a COVID-19 Screening Tool (U01 Clinical Trial Optional) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Education Health Income Security and Social Services |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.121 — Oral Diseases and Disorders Research |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Aug 06, 2020 |
Last Updated Date: | Aug 06, 2020 |
Original Closing Date for Applications: | Sep 15, 2020 |
Current Closing Date for Applications: | Sep 15, 2020 |
Archive Date: | Oct 21, 2020 |
Estimated Total Program Funding: | $7,000,000 |
Award Ceiling: | $500,000 |
Award Floor: | – |
Eligibility
Eligible Applicants: | County governments Native American tribal governments (Federally recognized) Public and State controlled institutions of higher education For profit organizations other than small businesses Private institutions of higher education State governments Independent school districts Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Small businesses Native American tribal organizations (other than Federally recognized tribal governments) Special district governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public housing authorities/Indian housing authorities Others (see text field entitled “Additional Information on Eligibility” for clarification) |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | NIH is issuing this RFA in response to the declared public health emergency issued by the Secretary, HHS, for 2019 Novel Coronavirus (COVID-19). This emergency NOSI from the NIH provides an expedited funding mechanism as part of the Rapid Acceleration of Diagnostics-Radical (RADx-rad) initiative. The goal of RADx-rad initiative is to encourage the development of novel, non-traditional approaches to identify the current SARS-CoV-2 virus or other markers of the COVID-19 disease that can be used in future outbreaks of COVID-19 and that could be applicable to other, as yet unknown, viruses. Specifically, the goal of this RFA is to solicit proposals to enhance the utility of chemosensory testing as a COVID-19 screening tool by using objective tests to examine the onset and prognostic value of chemosensory loss and to encourage the development and/or deployment of home-based and on-site chemosensory tests. The funding for this initiative is provided from the Paycheck Protection Program and Health Care Enhancement Act, 2020. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-OD-20-022.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
There are no related documents on this grant.
Packages
Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-F | Use for due dates on or after May 25, 2020 | PKG00262922 | Aug 15, 2020 | Sep 15, 2020 | View |
Package 1
Mandatory forms
328570 RR_SF424_2_0-2.0.pdf
328570 PHS398_CoverPageSupplement_5_0-5.0.pdf
328570 RR_OtherProjectInfo_1_4-1.4.pdf
328570 PerformanceSite_2_0-2.0.pdf
328570 RR_KeyPersonExpanded_2_0-2.0.pdf
328570 PHS398_ResearchPlan_4_0-4.0.pdf
328570 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
328570 RR_Budget_1_4-1.4.pdf
328570 RR_SubawardBudget30_1_4-1.4.pdf
328570 PHS398_ModularBudget_1_2-1.2.pdf
328570 PHS_AssignmentRequestForm_3_0-3.0.pdf